RIM
What does the future hold for regulatory information management?
February 12 by Romuald BraunRomauald Braun, VP of Strategy for Life Sciences at Amplexor discusses how organizations can gain additional value from their product data
Implementing ISO IDMP Standards - Implications to Regulatory Affairs and IT within Pharmaceutical Companies
April 16 by Pharmaceuticals & Biotechnology EditorThe International Standards for Identification of Medicinal Products, comprising of five ISO standards, were approved in 2012. These standards were designed to allow unambiguous identification of me...
Rules of Thumb for Pharmaceutical Information Management
December 16 by Pharma IQAlastair Scarlett, Regulatory Operations Project Manager at UCB Pharma, joins Helen Winsor from Pharma IQ to discuss developments in regulatory information management (RIM). In this exclusive int...
Building a Common Language: Boehringer Ingelheim Pharma GmbH & Co. KG on Interaction with Regulatory Bodies
April 25 by Torsten GrünewaldIn this exclusive interview Dr. Torsten Grünewald - Lead Business Architect at Boehringer Ingelheim Pharma GmbH & Co. KG expresses the need for a common language when interacting with...